Sector hub · about 2,100 companies
Healthcare stocks
Daily analysis · Oct 27, 2026
By size band, median one-day moves ranged from +1.4% for mega caps to -1.7% for micro caps, while Cumberland Pharmaceuticals Inc. (CPIX) recorded the largest decline at -48.8%.
- Amgen Inc. (AMGN34.SA): +8.9% one day move, mega cap
- Alnylam Pharmaceuticals, Inc. (A1LN34.SA): +9.1% one day move, large cap
- Surgery Partners, Inc. (SGRY): +47.6% one day move, mid cap
Generated from today's data · Not investment advice
Table
Showing 1 to 500 of 2,081 companies, largest market value first · page 1 of 5.
Data as of Oct 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.14T | Mega cap | +55.54% |
| JNJB34.SA | Johnson & Johnson | $650.82B | Mega cap | +42.00% |
| JNJ | Johnson & Johnson | $641.07B | Mega cap | +42.39% |
| ABBV34.SA | AbbVie Inc. | $509.93B | Mega cap | +28.42% |
| ABBV | AbbVie Inc. | $506.70B | Mega cap | +27.81% |
| MRK | Merck & Co., Inc. | $346.91B | Mega cap | +62.34% |
| NVS | Novartis AG | $292.35B | Mega cap | +22.73% |
| TMO | Thermo Fisher Scientific Inc. | $253.24B | Mega cap | +21.69% |
| AMGN34.SA | Amgen Inc. | $240.24B | Mega cap | +52.00% |
| AMGN | Amgen Inc. | $237.48B | Mega cap | +56.03% |
| GILD | Gilead Sciences, Inc. | $196.77B | Large cap | +33.35% |
| ABT | Abbott Laboratories | $182.68B | Large cap | −16.60% |
| NVO | Novo Nordisk A/S | $172.64B | Large cap | −23.30% |
| PFE | Pfizer Inc. | $169.79B | Large cap | +26.49% |
| DHR | Danaher Corporation | $163.77B | Large cap | +5.78% |
| I1SR34.SA | Intuitive Surgical, Inc. | $160.47B | Large cap | −17.27% |
| ISRG | Intuitive Surgical, Inc. | $159.55B | Large cap | −18.07% |
| VRTX | Vertex Pharmaceuticals Incorporated | $131.08B | Large cap | +23.16% |
| BMY | Bristol-Myers Squibb Company | $125.85B | Large cap | +45.15% |
| MDT | Medtronic plc | $121.25B | Large cap | +2.27% |
| MDTC34.SA | Medtronic plc | $121.25B | Large cap | −74.31% |
| S1YK34.SA | Stryker Corporation | $119.40B | Large cap | −21.25% |
| SYK | Stryker Corporation | $117.42B | Large cap | −19.81% |
| MCK | McKesson Corporation | $115.76B | Large cap | +22.57% |
| HCA | HCA Healthcare, Inc. | $103.21B | Large cap | −0.26% |
| GSK | GSK plc | $101.68B | Large cap | +19.72% |
| SNY | Sanofi | $99.68B | Large cap | −14.20% |
| SAN.PA | Sanofi | $95.34B | Large cap | −13.40% |
| ELV | Elevance Health, Inc. | $93.54B | Large cap | +27.37% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $83.26B | Large cap | +39.05% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.15B | Large cap | +38.54% |
| CI | The Cigna Group | $80.80B | Large cap | 0.00% |
| M1RN34.SA | Moderna, Inc. | $79.60B | Large cap | +629.79% |
| MRNA | Moderna, Inc. | $79.39B | Large cap | +645.87% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $72.04B | Large cap | +1.90% |
| MRK.DE | Merck KGaA | $66.19B | Large cap | +30.36% |
| BSX | Boston Scientific Corporation | $66.06B | Large cap | −55.50% |
| CSL.AX | CSL Limited | $65.73B | Large cap | −6.51% |
| 4502.T | Takeda Pharmaceutical Company Limited | $65.41B | Large cap | +48.78% |
| TAK | Takeda Pharmaceutical Company Limited | $65.27B | Large cap | +44.18% |
| COR | Cencora, Inc. | $62.97B | Large cap | −1.24% |
| NTRA | Natera, Inc. | $58.36B | Large cap | +110.64% |
| CAH | Cardinal Health, Inc. | $58.25B | Large cap | +54.32% |
| 7741.T | HOYA Corporation | $55.11B | Large cap | +7.88% |
| ARGX | argenx SE | $54.67B | Large cap | +4.76% |
| BDX | Becton, Dickinson and Company | $53.49B | Large cap | +35.14% |
| EW | Edwards Lifesciences Corporation | $52.14B | Large cap | +12.05% |
| VEEV | Veeva Systems Inc. | $51.52B | Large cap | +7.61% |
| 207940.KS | Samsung Biologics Co.,Ltd. | $50.97B | Large cap | −21.07% |
| HUM | Humana Inc. | $50.68B | Large cap | +43.93% |
| A | Agilent Technologies, Inc. | $49.61B | Large cap | +20.52% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $46.60B | Large cap | +106.98% |
| TEVA | Teva Pharmaceutical Industries Limited | $46.59B | Large cap | +103.72% |
| MDLN | Medline Inc. | $45.33B | Large cap | −17.83% |
| IQV | IQVIA Holdings Inc. | $45.03B | Large cap | +25.83% |
| IDXX | IDEXX Laboratories, Inc. | $44.98B | Large cap | −11.92% |
| HLN | Haleon plc | $44.86B | Large cap | +12.34% |
| WAT | Waters Corporation | $44.77B | Large cap | +29.63% |
| ONC | BeOne Medicines AG | $42.19B | Large cap | +17.58% |
| 4578.T | Otsuka Holdings Co., Ltd. | $41.68B | Large cap | +50.14% |
| ILMN | Illumina, Inc. | $40.93B | Large cap | +170.09% |
| RVMD | Revolution Medicines, Inc. | $40.08B | Large cap | +217.12% |
| RPRX | Royalty Pharma plc | $37.42B | Large cap | +76.47% |
| BIIB | Biogen Inc. | $37.27B | Large cap | +67.69% |
| RMD | ResMed Inc. | $35.61B | Large cap | −1.57% |
| RMD.AX | ResMed Inc. | $35.38B | Large cap | −9.74% |
| C1NC34.SA | Centene Corporation | $35.24B | Large cap | +107.68% |
| CNC | Centene Corporation | $33.61B | Large cap | +105.22% |
| MTD | Mettler-Toledo International Inc. | $33.47B | Large cap | +17.60% |
| ZTS | Zoetis Inc. | $33.46B | Large cap | −44.45% |
| GEHC | GE HealthCare Technologies Inc. | $32.74B | Large cap | −8.05% |
| 068270.KS | Celltrion, Inc. | $32.67B | Large cap | +9.42% |
| 4568.T | Daiichi Sankyo Company, Limited | $32.62B | Large cap | −28.59% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $30.46B | Large cap | −52.43% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $30.20B | Large cap | −52.23% |
| DXCM | DexCom, Inc. | $29.41B | Large cap | +11.24% |
| 4503.T | Astellas Pharma Inc. | $29.11B | Large cap | +55.87% |
| WST | West Pharmaceutical Services, Inc. | $27.78B | Large cap | +37.77% |
| GMAB | Genmab A/S | $27.48B | Large cap | +53.93% |
| DGX | Quest Diagnostics Incorporated | $26.82B | Large cap | +35.98% |
| LH | Labcorp Holdings Inc. | $26.75B | Large cap | +20.30% |
| ROIV | Roivant Sciences Ltd. | $26.04B | Large cap | +91.65% |
| PHG | Koninklijke Philips N.V. | $25.97B | Large cap | −4.45% |
| GH | Guardant Health, Inc. | $23.25B | Large cap | +144.53% |
| INCY | Incyte Corporation | $22.97B | Large cap | +21.73% |
| 4543.T | Terumo Corporation | $22.71B | Large cap | −5.70% |
| STE | STERIS plc | $22.44B | Large cap | −4.24% |
| SIG.AX | Sigma Healthcare Limited | $22.12B | Large cap | −10.38% |
| GMAB.CO | Genmab A/S | $21.74B | Large cap | +27.96% |
| THC | Tenet Healthcare Corporation | $21.66B | Large cap | +24.42% |
| VTRS | Viatris Inc. | $21.01B | Large cap | +80.40% |
| INSM | Insmed Incorporated | $20.38B | Large cap | −43.10% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.13B | Large cap | +13.36% |
| MEDP | Medpace Holdings, Inc. | $18.93B | Large cap | +13.46% |
| ZBH | Zimmer Biomet Holdings, Inc. | $18.59B | Large cap | −5.00% |
| RVTY | Revvity, Inc. | $17.72B | Large cap | +65.31% |
| CRL | Charles River Laboratories International, Inc. | $17.06B | Large cap | +82.95% |
| 4507.T | Shionogi & Co., Ltd. | $16.48B | Large cap | +23.61% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $16.35B | Large cap | +29.26% |
| EXEL | Exelixis, Inc. | $16.13B | Large cap | +62.82% |
| ASND | Ascendis Pharma A/S | $16.13B | Large cap | +20.63% |
| NBIX | Neurocrine Biosciences, Inc. | $14.83B | Large cap | −2.06% |
| PME.AX | Pro Medicus Limited | $14.76B | Large cap | −28.49% |
| SOLV | Solventum Corporation | $14.61B | Large cap | +19.21% |
| HALO | Halozyme Therapeutics, Inc. | $14.53B | Large cap | +94.40% |
| ICLR | ICON Public Limited Company | $14.18B | Large cap | +0.96% |
| JAZZ | Jazz Pharmaceuticals plc | $13.35B | Large cap | +47.64% |
| BBIO | BridgeBio Pharma, Inc. | $13.32B | Large cap | +7.22% |
| BAX | Baxter International Inc. | $13.07B | Large cap | +9.26% |
| PEN | Penumbra, Inc. | $12.81B | Large cap | +31.14% |
| SNN | Smith & Nephew plc | $12.75B | Large cap | −15.67% |
| EHC | Encompass Health Corporation | $12.24B | Large cap | −2.05% |
| TEM | Tempus AI, Inc. | $12.24B | Large cap | −26.67% |
| FMS | Fresenius Medical Care AG | $12.11B | Large cap | −12.99% |
| 7733.T | Olympus Corporation | $11.81B | Large cap | −10.27% |
| DVA | DaVita Inc. | $11.81B | Large cap | +42.05% |
| AVTR | Avantor, Inc. | $11.69B | Large cap | +14.43% |
| BTSG | BrightSpring Health Services, Inc. | $11.65B | Large cap | +74.05% |
| COO | The Cooper Companies, Inc. | $11.63B | Large cap | −16.07% |
| SMMT | Summit Therapeutics Inc. | $11.57B | Large cap | −25.49% |
| ELAN | Elanco Animal Health Incorporated | $11.47B | Large cap | +3.10% |
| RDY | Dr. Reddy's Laboratories Limited | $11.45B | Large cap | −4.98% |
| RGEN | Repligen Corporation | $11.44B | Large cap | +11.84% |
| TECH | Bio-Techne Corporation | $11.40B | Large cap | +13.65% |
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $11.20B | Large cap | −11.67% |
| UHS | Universal Health Services, Inc. | $10.95B | Large cap | −13.08% |
| GMED | Globus Medical, Inc. | $10.93B | Large cap | +29.36% |
| ALGN | Align Technology, Inc. | $10.82B | Large cap | +12.24% |
| BMRN | BioMarin Pharmaceutical Inc. | $10.79B | Large cap | +5.85% |
| MOH | Molina Healthcare, Inc. | $10.65B | Large cap | +26.27% |
| GKOS | Glaukos Corporation | $10.52B | Large cap | +135.56% |
| QGEN | Qiagen N.V. | $10.40B | Large cap | +4.07% |
| PODD | Insulet Corporation | $10.35B | Large cap | −54.19% |
| ENSG | The Ensign Group, Inc. | $10.31B | Large cap | −5.07% |
| APGE | Apogee Therapeutics Inc | $10.22B | Large cap | +140.21% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +0.65% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $10.11B | Large cap | +0.45% |
| BIO | Bio-Rad Laboratories, Inc. | $9.97B | Mid cap | +10.80% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +26.87% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.75B | Mid cap | +13.40% |
| TWST | Twist Bioscience Corporation | $9.63B | Mid cap | +324.96% |
| HSIC | Henry Schein, Inc. | $9.63B | Mid cap | +33.00% |
| OSCR | Oscar Health, Inc. | $9.60B | Mid cap | +58.11% |
| TXG | 10x Genomics, Inc. | $9.51B | Mid cap | +436.87% |
| PCVX | Vaxcyte, Inc. | $9.44B | Mid cap | +34.55% |
| CORT | Corcept Therapeutics Incorporated | $9.42B | Mid cap | +20.07% |
| KRYS | Krystal Biotech, Inc. | $9.28B | Mid cap | +65.15% |
| KYMR | Kymera Therapeutics, Inc. | $9.21B | Mid cap | +88.73% |
| CAI | Caris Life Sciences, Inc. | $9.17B | Mid cap | +7.29% |
| 4523.T | Eisai Co., Ltd. | $9.13B | Mid cap | +11.89% |
| PTGX | Protagonist Therapeutics, Inc. | $9.08B | Mid cap | +86.47% |
| HNGE | Hinge Health, Inc. | $9.01B | Mid cap | +124.00% |
| CRNX | Crinetics Pharmaceuticals Inc | $9.01B | Mid cap | +91.59% |
| RHC.AX | Ramsay Health Care Limited | $8.90B | Mid cap | +73.83% |
| BRKR | Bruker Corporation | $8.87B | Mid cap | +51.08% |
| HQY | HealthEquity, Inc. | $8.58B | Mid cap | +7.88% |
| CYTK | Cytokinetics, Incorporated | $8.51B | Mid cap | +0.91% |
| SYRE | Spyre Therapeutics, Inc. | $8.44B | Mid cap | +278.14% |
| TGTX | TG Therapeutics, Inc. | $8.39B | Mid cap | +62.63% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $8.31B | Mid cap | +49.39% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.14B | Mid cap | +4.15% |
| ATR | AptarGroup, Inc. | $8.08B | Mid cap | −0.56% |
| 2413.T | M3, Inc. | $8.04B | Mid cap | −12.61% |
| PACS | PACS Group, Inc. | $7.72B | Mid cap | +286.98% |
| ABVX | ABIVAX Société Anonyme | $7.57B | Mid cap | −8.79% |
| AXSM | Axsome Therapeutics, Inc. | $7.55B | Mid cap | +6.96% |
| 6869.T | Sysmex Corporation | $7.54B | Mid cap | +8.87% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.47B | Mid cap | +36.24% |
| ALKS | Alkermes plc | $7.46B | Mid cap | +49.53% |
| AMRX | Amneal Pharmaceuticals, Inc. | $7.32B | Mid cap | +105.07% |
| IONS | Ionis Pharmaceuticals, Inc. | $7.22B | Mid cap | −40.51% |
| PRAX | Praxis Precision Medicines, Inc. | $7.06B | Mid cap | +43.80% |
| CHE | Chemed Corporation | $6.70B | Mid cap | +17.74% |
| 3088.T | MatsukiyoCocokara & Co. | $6.63B | Mid cap | −8.09% |
| SHL.AX | Sonic Healthcare Limited | $6.62B | Mid cap | −9.95% |
| LNTH | Lantheus Holdings, Inc. | $6.52B | Mid cap | +71.89% |
| COH.AX | Cochlear Limited | $6.51B | Mid cap | −50.24% |
| 3391.T | Tsuruha Holdings Inc. | $6.49B | Mid cap | −15.60% |
| HIMS | Hims & Hers Health, Inc. | $6.44B | Mid cap | −42.79% |
| GRAL | GRAIL, Inc. | $6.25B | Mid cap | +64.60% |
| IOVA | Iovance Biotherapeutics, Inc. | $6.24B | Mid cap | +496.54% |
| 0126Z0.KS | Samsung Epis Holdings Co., Ltd. | $6.22B | Mid cap | −1.04% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.20B | Mid cap | +49.78% |
| LGND | Ligand Pharmaceuticals Incorporated | $6.15B | Mid cap | +62.29% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $6.14B | Mid cap | −19.79% |
| DOCS | Doximity, Inc. | $5.90B | Mid cap | −51.71% |
| IMVT | Immunovant, Inc. | $5.82B | Mid cap | +31.45% |
| TFX | Teleflex Incorporated | $5.80B | Mid cap | +4.10% |
| BLTE | Belite Bio, Inc | $5.77B | Mid cap | +52.79% |
| MANE | Veradermics, Incorporated | $5.74B | Mid cap | +263.95% |
| KOD | Kodiak Sciences Inc. | $5.63B | Mid cap | +375.84% |
| MMSI | Merit Medical Systems, Inc. | $5.62B | Mid cap | +13.84% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $5.61B | Mid cap | +79.75% |
| RDNT | RadNet, Inc. | $5.51B | Mid cap | −14.19% |
| WAY | Waystar Holding Corp. | $5.50B | Mid cap | −27.05% |
| CGON | CG Oncology, Inc. | $5.46B | Mid cap | +38.99% |
| HAE | Haemonetics Corporation | $5.42B | Mid cap | +132.75% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.41B | Mid cap | +16.33% |
| GRFS | Grifols, S.A. | $5.39B | Mid cap | −15.57% |
| COGT | Cogent Biosciences, Inc. | $5.36B | Mid cap | +90.80% |
| STVN | Stevanato Group S.p.A. | $5.32B | Mid cap | −23.48% |
| ORKA | Oruka Therapeutics, Inc. | $5.31B | Mid cap | +226.10% |
| BLLN | BillionToOne, Inc. | $5.26B | Mid cap | +2.32% |
| MMED | MiniMed Group, Inc. | $5.25B | Mid cap | +0.92% |
| SHC | Sotera Health Company | $5.25B | Mid cap | +10.05% |
| ERAS | Erasca, Inc. | $5.24B | Mid cap | +527.20% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $5.23B | Mid cap | +9.54% |
| CON | Concentra Group Holdings Parent, Inc. | $5.13B | Mid cap | +94.97% |
| PTCT | PTC Therapeutics, Inc. | $5.10B | Mid cap | −8.96% |
| SRRK | Scholar Rock Holding Corporation | $5.08B | Mid cap | +36.75% |
| LFST | LifeStance Health Group, Inc. | $4.96B | Mid cap | +155.58% |
| HTFL | Heartflow, Inc. | $4.96B | Mid cap | +48.68% |
| DFTX | Definium Therapeutics, Inc. | $4.79B | Mid cap | +178.10% |
| OPCH | Option Care Health, Inc. | $4.68B | Mid cap | +12.18% |
| TVTX | Travere Therapeutics, Inc. | $4.65B | Mid cap | +67.85% |
| 000100.KS | Yuhan Corporation | $4.61B | Mid cap | −28.74% |
| ANN.AX | Ansell Limited | $4.59B | Mid cap | +39.19% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.54B | Mid cap | −33.25% |
| LIVN | LivaNova PLC | $4.44B | Mid cap | +48.53% |
| 7459.T | MediPal Holdings Corporation | $4.41B | Mid cap | +24.03% |
| DNTH | Dianthus Therapeutics, Inc. | $4.34B | Mid cap | +136.66% |
| ITGR | Integer Holdings Corporation | $4.30B | Mid cap | +80.23% |
| EWTX | Edgewise Therapeutics, Inc. | $4.25B | Mid cap | +144.35% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +53.45% |
| ICUI | ICU Medical, Inc. | $4.15B | Mid cap | +35.03% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.08B | Mid cap | +39.47% |
| IRTC | iRhythm Holdings, Inc. | $4.02B | Mid cap | −33.27% |
| ARQT | Arcutis Biotherapeutics, Inc. | $4.00B | Mid cap | +61.97% |
| RLAY | Relay Therapeutics, Inc. | $3.97B | Mid cap | +145.53% |
| LEGN | Legend Biotech Corporation | $3.97B | Mid cap | −36.52% |
| LQDA | Liquidia Corporation | $3.92B | Mid cap | +92.18% |
| ABCL | AbCellera Biologics Inc. | $3.91B | Mid cap | +109.36% |
| 000105.KS | Yuhan Corporation | $3.90B | Mid cap | −33.07% |
| VCYT | Veracyte, Inc. | $3.85B | Mid cap | +34.00% |
| NVST | Envista Holdings Corporation | $3.80B | Mid cap | +16.27% |
| PLSE | Pulse Biosciences, Inc. | $3.76B | Mid cap | +200.91% |
| TNGX | Tango Therapeutics, Inc. | $3.74B | Mid cap | +185.65% |
| NHC | National HealthCare Corporation | $3.70B | Mid cap | +87.43% |
| OGN | Organon & Co. | $3.61B | Mid cap | +95.92% |
| CDNA | CareDx, Inc. | $3.57B | Mid cap | +376.22% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.55B | Mid cap | +13.55% |
| XENE | Xenon Pharmaceuticals Inc. | $3.46B | Mid cap | −15.64% |
| IRON | Disc Medicine, Inc. | $3.45B | Mid cap | −13.37% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.40B | Mid cap | +90.37% |
| ACAD | Acadia Pharmaceuticals Inc. | $3.38B | Mid cap | −14.14% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $3.37B | Mid cap | −15.23% |
| RGC | Regencell Bioscience Holdings Limited | $3.35B | Mid cap | −59.06% |
| CELC | Celcuity Inc. | $3.22B | Mid cap | −15.11% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.21B | Mid cap | −12.26% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.19B | Mid cap | +2.74% |
| IMR.AX | Imricor Medical Systems, Inc. | $3.19B | Mid cap | −8.90% |
| IDYA | IDEAYA Biosciences, Inc. | $3.17B | Mid cap | +1.58% |
| WRBY | Warby Parker Inc. | $3.12B | Mid cap | +17.58% |
| ATRC | AtriCure, Inc. | $3.11B | Mid cap | +67.48% |
| VKTX | Viking Therapeutics, Inc. | $3.08B | Mid cap | −32.62% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.06B | Mid cap | −22.92% |
| TLX | Telix Pharmaceuticals Limited | $3.05B | Mid cap | −17.90% |
| ELVN | Enliven Therapeutics, Inc. | $3.04B | Mid cap | +93.88% |
| 7649.T | Sugi Holdings Co.,Ltd. | $2.98B | Mid cap | −63.47% |
| DNLI | Denali Therapeutics Inc. | $2.98B | Mid cap | +15.11% |
| DYN | Dyne Therapeutics, Inc. | $2.94B | Mid cap | −34.96% |
| ACHC | Acadia Healthcare Company, Inc. | $2.92B | Mid cap | +36.56% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.88B | Mid cap | +36.86% |
| PRVA | Privia Health Group, Inc. | $2.86B | Mid cap | −13.87% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $2.81B | Mid cap | +126.95% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +113.27% |
| 2784.T | Alfresa Holdings Corporation | $2.75B | Mid cap | +10.09% |
| ZLAB | Zai Lab Limited | $2.73B | Mid cap | −7.59% |
| ATAI | AtaiBeckley Inc. | $2.73B | Mid cap | +18.17% |
| 9989.T | Sundrug Co.,Ltd. | $2.72B | Mid cap | −12.16% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.67B | Mid cap | +9.39% |
| NEOG | Neogen Corporation | $2.67B | Mid cap | +96.62% |
| VRDN | Viridian Therapeutics, Inc. | $2.64B | Mid cap | +3.55% |
| ONT.L | Oxford Nanopore Technologies plc | $2.60B | Mid cap | +48.16% |
| 9987.T | Suzuken Co., Ltd. | $2.53B | Mid cap | −51.37% |
| EBO.AX | EBOS Group Limited | $2.50B | Mid cap | −29.95% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.48B | Mid cap | +34.91% |
| HCM | HUTCHMED (China) Limited | $2.48B | Mid cap | −3.97% |
| ADMA | ADMA Biologics, Inc. | $2.48B | Mid cap | −29.07% |
| BEAM | Beam Therapeutics Inc. | $2.46B | Mid cap | −11.00% |
| TMDX | TransMedics Group, Inc. | $2.44B | Mid cap | −46.67% |
| CLOV | Clover Health Investments, Corp. | $2.42B | Mid cap | +19.69% |
| MBX | MBX Biosciences, Inc. | $2.42B | Mid cap | +188.36% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.37B | Mid cap | −22.67% |
| MD | Pediatrix Medical Group, Inc. | $2.36B | Mid cap | +66.51% |
| NAMS | NewAmsterdam Pharma Company N.V. | $2.33B | Mid cap | −45.81% |
| BKD | Brookdale Senior Living Inc. | $2.33B | Mid cap | +11.54% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.33B | Mid cap | +484.54% |
| CLDX | Celldex Therapeutics, Inc. | $2.32B | Mid cap | +7.78% |
| PBH | Prestige Consumer Healthcare Inc. | $2.28B | Mid cap | −22.85% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.27B | Mid cap | +38.65% |
| FTRE | Fortrea Holdings Inc. | $2.27B | Mid cap | +129.36% |
| ADUS | Addus HomeCare Corporation | $2.26B | Mid cap | −0.24% |
| RCUS | Arcus Biosciences, Inc. | $2.26B | Mid cap | −4.52% |
| UFPT | UFP Technologies, Inc. | $2.26B | Mid cap | +45.63% |
| AXGN | Axogen, Inc. | $2.23B | Mid cap | +113.96% |
| PRGO | Perrigo Company plc | $2.21B | Mid cap | −26.28% |
| PHVS | Pharvaris N.V. | $2.21B | Mid cap | +38.21% |
| AGIO | Agios Pharmaceuticals, Inc. | $2.20B | Mid cap | −14.46% |
| BHVN | Biohaven Ltd. | $2.18B | Mid cap | −16.91% |
| VCEL | Vericel Corporation | $2.18B | Mid cap | +18.01% |
| NEO | NeoGenomics, Inc. | $2.17B | Mid cap | +64.27% |
| XNCR | Xencor, Inc. | $2.17B | Mid cap | +104.48% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.16B | Mid cap | +2.51% |
| PGNY | Progyny, Inc. | $2.16B | Mid cap | +44.03% |
| PGEN | Precigen, Inc. | $2.15B | Mid cap | +40.47% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.14B | Mid cap | +22.32% |
| IMNM | Immunome, Inc. | $2.11B | Mid cap | +7.77% |
| ALMR | Alamar Biosciences, Inc. | $2.11B | Mid cap | +38.14% |
| LKFT | Lakefront Biotherapeutics NV | $2.09B | Mid cap | +2.05% |
| SGRY | Surgery Partners, Inc. | $2.06B | Mid cap | +1.53% |
| INSP | Inspire Medical Systems, Inc. | $2.05B | Mid cap | −9.19% |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.04B | Mid cap | −39.68% |
| ZYME | Zymeworks Inc. | $2.04B | Mid cap | +53.60% |
| EKTA-B.ST | Elekta AB (publ) | $2.03B | Mid cap | +17.00% |
| VERA | Vera Therapeutics, Inc. | $2.02B | Mid cap | −6.94% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.01B | Mid cap | +7.80% |
| 302440.KS | SK bioscience Co.,Ltd. | $1.96B | Small cap | −36.98% |
| ESTA | Establishment Labs Holdings Inc. | $1.96B | Small cap | +29.46% |
| LMAT | LeMaitre Vascular, Inc. | $1.93B | Small cap | −5.78% |
| AMN | AMN Healthcare Services, Inc. | $1.90B | Small cap | +133.22% |
| BLFS | BioLife Solutions Inc | $1.89B | Small cap | +37.70% |
| SEPN | Septerna, Inc. | $1.89B | Small cap | +82.94% |
| 6960.T | Fukuda Denshi Co., Ltd. | $1.88B | Small cap | +50.60% |
| SRPT | Sarepta Therapeutics, Inc. | $1.87B | Small cap | −23.49% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +78.35% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.86B | Small cap | +9.67% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.85B | Small cap | +29.16% |
| ASTH | Astrana Health, Inc. | $1.85B | Small cap | +12.65% |
| XRAY | DENTSPLY SIRONA Inc. | $1.84B | Small cap | −28.55% |
| MLYS | Mineralys Therapeutics, Inc. | $1.81B | Small cap | −49.31% |
| PVLA | Palvella Therapeutics, Inc. | $1.80B | Small cap | +79.23% |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +3.83% |
| EMEIS.PA | emeis Société anonyme | $1.79B | Small cap | −29.09% |
| TRVI | Trevi Therapeutics, Inc. | $1.78B | Small cap | +19.14% |
| SDGR | Schrödinger, Inc. | $1.78B | Small cap | +10.51% |
| ZBIO | Zenas BioPharma, Inc. | $1.78B | Small cap | −14.34% |
| BFLY | Butterfly Network, Inc. | $1.77B | Small cap | +202.73% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.75B | Small cap | +8.68% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.75B | Small cap | −12.52% |
| MAZE | Maze Therapeutics, Inc. | $1.73B | Small cap | +0.23% |
| ARDT | Ardent Health, Inc. | $1.72B | Small cap | −19.55% |
| HCSG | Healthcare Services Group, Inc. | $1.69B | Small cap | +32.63% |
| PSNL | Personalis, Inc. | $1.69B | Small cap | +64.05% |
| OMCL | Omnicell, Inc. | $1.69B | Small cap | +21.05% |
| COAG | Hemab Therapeutics Holdings, Inc. | $1.68B | Small cap | +5.94% |
| NVCR | NovoCure Limited | $1.68B | Small cap | +6.04% |
| ATEC | Alphatec Holdings, Inc. | $1.68B | Small cap | −34.26% |
| WGS | GeneDx Holdings Corp. | $1.67B | Small cap | −53.11% |
| 8129.T | Toho Holdings Co., Ltd. | $1.67B | Small cap | −20.46% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.67B | Small cap | −21.82% |
| URGN | UroGen Pharma Ltd. | $1.66B | Small cap | +63.26% |
| KLRA | Kailera Therapeutics, Inc. | $1.66B | Small cap | −50.88% |
| ALVO | Alvotech | $1.65B | Small cap | −43.17% |
| STOK | Stoke Therapeutics, Inc. | $1.64B | Small cap | −22.85% |
| ALHC | Alignment Healthcare, Inc. | $1.64B | Small cap | −55.60% |
| FBRX | Forte Biosciences Inc | $1.63B | Small cap | +492.23% |
| MSB.AX | Mesoblast Limited | $1.63B | Small cap | −30.27% |
| 6849.T | Nihon Kohden Corporation | $1.62B | Small cap | −12.86% |
| ABSI | Absci Corporation | $1.62B | Small cap | +110.00% |
| CERT | Certara, Inc. | $1.62B | Small cap | −15.19% |
| SNDA | Sonida Senior Living, Inc. | $1.61B | Small cap | +28.26% |
| IMCR | Immunocore Holdings plc | $1.61B | Small cap | −6.52% |
| MESO | Mesoblast Limited | $1.61B | Small cap | −25.85% |
| NBTX | Nanobiotix S.A. | $1.61B | Small cap | +109.08% |
| AZTA | Azenta, Inc. | $1.60B | Small cap | +16.59% |
| RARE | Ultragenyx Pharmaceutical Inc. | $1.59B | Small cap | −54.46% |
| GENB | Generate Biomedicines, Inc. | $1.59B | Small cap | −2.37% |
| PAHC | Phibro Animal Health Corporation | $1.58B | Small cap | −5.93% |
| NUVB | Nuvation Bio Inc. | $1.58B | Small cap | −10.52% |
| NTLA | Intellia Therapeutics, Inc. | $1.58B | Small cap | −23.87% |
| 4DX.AX | 4DMedical Limited | $1.56B | Small cap | +92.19% |
| SIA.TO | Sienna Senior Living Inc. | $1.56B | Small cap | +7.10% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.55B | Small cap | +128.84% |
| NVAX | Novavax, Inc. | $1.55B | Small cap | +8.05% |
| CMPS | COMPASS Pathways plc | $1.53B | Small cap | +68.96% |
| INVA | Innoviva, Inc. | $1.52B | Small cap | +18.79% |
| 4483.T | JMDC Inc. | $1.52B | Small cap | −23.03% |
| AGL | agilon health, inc. | $1.52B | Small cap | +281.99% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.51B | Small cap | −2.19% |
| GPCR | Structure Therapeutics Inc. | $1.50B | Small cap | −26.35% |
| QURE | uniQure N.V. | $1.50B | Small cap | −68.12% |
| PNTG | The Pennant Group, Inc. | $1.49B | Small cap | +68.53% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $1.48B | Small cap | +15.52% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.47B | Small cap | +9.51% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.46B | Small cap | +4.08% |
| ANAB | AnaptysBio, Inc. | $1.46B | Small cap | +102.20% |
| PCRX | Pacira BioSciences, Inc. | $1.45B | Small cap | +70.56% |
| AAPG | Ascentage Pharma Group Internat | $1.44B | Small cap | −55.30% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +140.43% |
| 7716.T | Nakanishi Inc. | $1.43B | Small cap | −34.78% |
| NUTX | Nutex Health Inc. | $1.43B | Small cap | +61.42% |
| ETON | Eton Pharmaceuticals, Inc. | $1.43B | Small cap | +171.48% |
| CNMD | CONMED Corporation | $1.43B | Small cap | +0.68% |
| OCUL | Ocular Therapeutix, Inc. | $1.42B | Small cap | −43.98% |
| TYRA | Tyra Biosciences, Inc. | $1.40B | Small cap | +37.60% |
| 8086.T | Nipro Corporation | $1.40B | Small cap | −12.75% |
| 2175.T | SMS Co., Ltd. | $1.36B | Small cap | +67.60% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.34B | Small cap | +2.00% |
| USPH | U.S. Physical Therapy, Inc. | $1.32B | Small cap | −0.66% |
| GHRS | GH Research PLC | $1.32B | Small cap | +33.99% |
| TNDM | Tandem Diabetes Care, Inc. | $1.32B | Small cap | +26.51% |
| DMRA | Damora Therapeutics, Inc. | $1.31B | Small cap | +189.45% |
| SPI.L | Spire Healthcare Group plc | $1.31B | Small cap | +4.67% |
| TSHA | Taysha Gene Therapies, Inc. | $1.31B | Small cap | −17.83% |
| 4544.T | H.U. Group Holdings, Inc. | $1.31B | Small cap | −3.25% |
| INBX | Inhibrx Biosciences, Inc. | $1.30B | Small cap | +50.57% |
| INNV | InnovAge Holding Corp. | $1.30B | Small cap | +84.66% |
| NKTR | Nektar Therapeutics | $1.28B | Small cap | −40.15% |
| LBRX | LB Pharmaceuticals Inc | $1.27B | Small cap | +135.57% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.26B | Small cap | −9.41% |
| 9627.T | Ain Holdings Inc. | $1.26B | Small cap | −15.10% |
| SLN | Silence Therapeutics plc | $1.23B | Small cap | +177.03% |
| OPK | OPKO Health, Inc. | $1.22B | Small cap | +12.41% |
| ENOV | Enovis Corporation | $1.22B | Small cap | −35.61% |
| RAPP | Rapport Therapeutics, Inc. | $1.22B | Small cap | −4.34% |
| GDRX | GoodRx Holdings, Inc. | $1.21B | Small cap | −5.57% |
| PYC.AX | PYC Therapeutics Limited | $1.21B | Small cap | +43.85% |
| AVLN | Avalyn Pharma Inc. | $1.20B | Small cap | −7.97% |
| 7476.T | AS ONE Corporation | $1.20B | Small cap | +2.47% |
| DRTS | Alpha Tau Medical Ltd. | $1.19B | Small cap | +209.86% |
| OMER | Omeros Corporation | $1.18B | Small cap | +111.28% |
| OMDA | Omada Health, Inc. | $1.18B | Small cap | −27.18% |
| 4588.T | Oncolys BioPharma Inc. | $1.18B | Small cap | +723.61% |
| REPL | Replimune Group, Inc. | $1.17B | Small cap | +33.65% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.17B | Small cap | +0.84% |
| BIOG-B.ST | BioGaia AB (publ) | $1.17B | Small cap | +21.76% |
| STAA | STAAR Surgical Company | $1.16B | Small cap | −16.38% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −30.74% |
| PRCT | PROCEPT BioRobotics Corporation | $1.14B | Small cap | −45.45% |
| 006280.KS | GC Biopharma Corp. | $1.14B | Small cap | +0.62% |
| 2160.T | GNI Group Ltd. | $1.13B | Small cap | +7.82% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.13B | Small cap | −36.61% |
| AORT | Artivion, Inc. | $1.12B | Small cap | −48.64% |
| BCAX | Bicara Therapeutics Inc. | $1.12B | Small cap | −0.65% |
| SPTX | Seaport Therapeutics, Inc. | $1.12B | Small cap | +4.99% |
| IMTX | Immatics N.V. | $1.11B | Small cap | −32.42% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.11B | Small cap | +22.97% |
| BBNX | Beta Bionics, Inc. | $1.11B | Small cap | −13.64% |
| AHG | Akso Health Group | $1.09B | Small cap | −22.56% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.08B | Small cap | +5.95% |
| IRMD | IRADIMED CORPORATION | $1.08B | Small cap | +10.13% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.08B | Small cap | +24.02% |
| HSTM | HealthStream, Inc. | $1.07B | Small cap | +34.82% |
| CBLL | CeriBell, Inc. | $1.04B | Small cap | +109.70% |
| MNKD | MannKind Corporation | $1.04B | Small cap | −40.41% |
| 6523.T | PHC Holdings Corporation | $1.04B | Small cap | +23.36% |
| RYM.AX | Ryman Healthcare Limited | $1.04B | Small cap | −43.16% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.02B | Small cap | −7.11% |
| JANX | Janux Therapeutics, Inc. | $1.02B | Small cap | −38.98% |
| REG.AX | Regis Healthcare Limited | $1.02B | Small cap | −33.00% |
| CSTL | Castle Biosciences, Inc. | $1.01B | Small cap | +38.98% |
| MLTX | MoonLake Immunotherapeutics | $1.01B | Small cap | +17.28% |
| BVS | Bioventus Inc. | $1.01B | Small cap | +119.37% |
| SGP | SpyGlass Pharma, Inc. | $1.00B | Small cap | +13.30% |
| VOR | Vor Biopharma Inc. | $993.23M | Small cap | −34.84% |
| SIBN | SI-BONE, Inc. | $945.08M | Small cap | +36.08% |
| QDEL | QuidelOrtho Corporation | $944.28M | Small cap | −53.29% |
| 7730.T | Mani, Inc. | $943.36M | Small cap | −0.27% |
| CGEM | Cullinan Therapeutics, Inc. | $935.72M | Small cap | +80.40% |
| ORIC | ORIC Pharmaceuticals, Inc. | $928.21M | Small cap | −33.17% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $927.69M | Small cap | +6.61% |
| ODTX | Odyssey Therapeutics, Inc. | $927.53M | Small cap | +17.54% |
| IART | Integra LifeSciences Holdings Corporation | $926.27M | Small cap | −24.04% |
| JBIO | Jade Biosciences, Inc. | $922.16M | Small cap | +42.30% |
| 4694.T | BML, Inc. | $907.56M | Small cap | +2.13% |
| VSTM | Verastem, Inc. | $905.63M | Small cap | +14.68% |
| GLUE | Monte Rosa Therapeutics, Inc. | $894.08M | Small cap | −14.94% |
| 7780.T | Menicon Co., Ltd. | $891.65M | Small cap | +56.06% |
| RIGL | Rigel Pharmaceuticals, Inc. | $890.51M | Small cap | +68.73% |
| 3046.T | JINS HOLDINGS Inc. | $889.09M | Small cap | −25.90% |
| SNZ.AX | Summerset Group Holdings Limited | $887.41M | Small cap | −45.91% |
| TBPH | Theravance Biopharma Inc | $884.18M | Small cap | +19.09% |
| MGTX | MeiraGTx Holdings plc | $881.67M | Small cap | +3.49% |
| CRVS | Corvus Pharmaceuticals, Inc. | $879.06M | Small cap | +32.95% |
| AKTS | Aktis Oncology, Inc. | $874.89M | Small cap | −29.78% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $872.81M | Small cap | −26.66% |
| TALK | Talkspace Inc | $870.57M | Small cap | +92.31% |
| ANRO | Alto Neuroscience, Inc. | $867.64M | Small cap | +80.49% |
| 4587.T | PeptiDream Inc. | $865.74M | Small cap | −35.53% |
| SVRA | Savara Inc. | $864.79M | Small cap | +3.20% |
| IVA | Inventiva S.A. | $864.57M | Small cap | −46.96% |
| KURA | Kura Oncology, Inc. | $855.80M | Small cap | −12.86% |
| 001067.KS | JW Pharmaceutical Corporation | $853.93M | Small cap | −17.21% |
| ALMS | Alumis Inc. | $842.62M | Small cap | +35.34% |
| PHAR | Pharming Group N.V. | $842.26M | Small cap | −10.73% |
| NEU.WA | NEUCA S.A. | $816.94M | Small cap | −5.05% |
| AHCO | AdaptHealth Corp. | $806.80M | Small cap | −36.98% |
| SFL.MI | Safilo Group S.p.A. | $803.08M | Small cap | +6.00% |
| PIII | P3 Health Partners Inc. | $790.70M | Small cap | −56.11% |
| 4565.T | Nxera Pharma Co., Ltd. | $790.44M | Small cap | +37.89% |
| INMD | InMode Ltd. | $789.51M | Small cap | −12.33% |
| PHR | Phreesia, Inc. | $782.71M | Small cap | −46.27% |
| VREX | Varex Imaging Corporation | $781.75M | Small cap | +54.45% |
| ARDX | Ardelyx, Inc. | $774.56M | Small cap | −41.18% |
| CTKB | Cytek Biosciences, Inc. | $765.60M | Small cap | +41.93% |
| AVBP | ArriVent BioPharma, Inc. | $757.37M | Small cap | −21.19% |
| HELP | Cybin D/B/A Helus Pharma | $757.00M | Small cap | +59.14% |
| PHN.MI | Pharmanutra S.p.A. | $756.30M | Small cap | +49.81% |
| COLL | Collegium Pharmaceutical, Inc. | $755.62M | Small cap | −33.33% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 2,081 companies in the Healthcare sector. The median market value in the group is $745.56M, measured across the 1,000 largest of them. Among the 698 with a price from the latest session, the median move over the past trading day is 0.00%. 42% of the 976 with a 200-day average trade above it. Price change over the past year runs from −53.4% to +90.9% across the middle 80 percent of the group, with a median of −1.0%. Among those 1,000, 4 companies currently carry a tier A volume signal.